Category Archives: Cell Therapy

Stem Cell Therapy Treatment for Inclusive Body Myopathy by Dr Alok Sharma, Mumbai, India. Part 2 Stem Cell Therapy Treatment for Inclusive Body Myopathy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1) Muscle girth has increased at bilateral ... By: neurogenbsi … Continue reading →

TakoBar Cell Therapy Featuring J-Blev and Southside Eaze E late night freestyle session with @JBlev and @Southsideeazee at TakeBar (818 Juniper St. Atlanta,Ga). Just a friendly PSA to let yu know that we really do tu... By: She730 … Continue reading →

Performance After Adipose Stem Cell Therapy for Horse - Cash Fuez and Flaxey Performance After Adipose Stem Cell Therapy for Horse - Cash Fuez and Flaxey http://wichitaequinevet.com "This is the video of Flaxey after he and Cash won t... By: WichitaEquine … Continue reading →

PS3 BF3: Goodie Mob - Cell Therapy : Busta Rhymes - Break Ya Neck : Scarface - Homies Thugs I do not own the copyright to the music, and no infringement intended. For entertainment purposes only* a little bit of rush on kharg island with rush_n_ata... By: beevotchi i … Continue reading →

Stem Cell Therapy for Pets - Teddy Before After Amazing before and after footage of Teddy, an 11 year old dog who received stem cell therapy for his arthritis and received an unexpected benefit to his hear... By: NewmanVets … Continue reading →

Stem Cell Therapy for Pets -- Taylor Before After Amazing before and after footage of Taylor, a 7 year old dog who received stem cell therapy for arthritis in her hips, knees and ankles. For more information... By: NewmanVets … Continue reading →

Public release date: 3-Apr-2013 [ | E-mail | Share ] Contact: Jeffrey Norris jeff.norris@ucsf.edu 415-502-6397 University of California - San Francisco Treating patients with cells may one day become as common as it is now to treat the sick with drugs made from engineered proteins, antibodies or smaller chemicals, according to UC San Francisco researchers. They outlined their vision of cell-based therapeutics as a "third pillar of medicine" in an article published online April 3 in Science Translational Medicine. "Today, biomedical science sits on the cusp of a revolution: the use of human and microbial cells as therapeutic entities," said Wendell Lim, PhD, a UCSF professor and director of the UCSF Center for Systems and Synthetic Biology, and one of the article's co-authors. Cell therapies have the potential to address critical, unmet needs in the treatment of some of the deadliest diseases, including diabetes, cancer and inflammatory bowel diseases, the scientists said. The reason, they said, is that cells can carry out functions that can't be performed by small-molecule drugs produced by Big Pharma, or by targeted drugs developed by biotech firms in the wake of the genetic engineering revolution. For one, cells are adaptable. They can sense their surroundings … Continue reading →

Public release date: 3-Apr-2013 [ | E-mail | Share ] Contact: Jeffrey Norris jeff.norris@ucsf.edu 415-502-6397 University of California - San Francisco Treating patients with cells may one day become as common as it is now to treat the sick with drugs made from engineered proteins, antibodies or smaller chemicals, according to UC San Francisco researchers. They outlined their vision of cell-based therapeutics as a "third pillar of medicine" in an article published online April 3 in Science Translational Medicine. "Today, biomedical science sits on the cusp of a revolution: the use of human and microbial cells as therapeutic entities," said Wendell Lim, PhD, a UCSF professor and director of the UCSF Center for Systems and Synthetic Biology, and one of the article's co-authors. Cell therapies have the potential to address critical, unmet needs in the treatment of some of the deadliest diseases, including diabetes, cancer and inflammatory bowel diseases, the scientists said. The reason, they said, is that cells can carry out functions that can't be performed by small-molecule drugs produced by Big Pharma, or by targeted drugs developed by biotech firms in the wake of the genetic engineering revolution. For one, cells are adaptable. They can sense their surroundings … Continue reading →

Image Caption: (Left Image) For some medical applications, cell therapies are better equipped than small-molecule or genetically-engineered drugs. For instance, individually tailored, induced pluripotent stem cells might be used to regenerate damaged organs or tissues. (Right Image) In this example of the advantages of cell therapies, bacteria may be programmed to make an anti-inflammatory molecule and transplanted to the gut to treat inflammatory bowel disease. Credit: Science Translational Medicine April Flowers for redOrbit.com Your Universe Online A new study from the University of California, San Francisco (UCSF) reveals that treating patients with cells may one day become as common as it is now to treat the sick with drugs from engineered proteins, antibodies, or smaller chemicals. The team outlines their vision of cell-based therapy as a third pillar of medicine in an online edition of Science Translational Medicine. Today, biomedical science sits on the cusp of a revolution: the use of human and microbial cells as therapeutic entities, said Wendell Lim, PhD, a UCSF professor and director of the UCSF Center for Systems and Synthetic Biology. According to the scientists, cell therapies have the potential to address critical, unmet needs in the treatment of some of the deadliest diseases. These … Continue reading →

Italian health officials are allowing a handful of patients to continue with a controversial stem cell therapy amid protests from scientists that the treatments are unproven and unsafe. The Stamina Foundation has been administering the therapy at the public hospital Spedali Civili of Brescia to people with a range of degenerative diseases. Their approach is based on mesenchymal stem cells, derived from bone marrow, which can become mature bone and connective tissue. In 2011 the hospital agreed to host the research and assist with cell extraction and patient treatments, stirring protests from the medical community. "The hospital is not even listed among the 13 Italian authorised stem cell factories," says Michele de Luca, director and gene therapy programme coordinator at the Centre for Regenerative Medicine in Modena. After an inspection in 2012, Italian drug regulator AIFA ordered an immediate halt to Stamina's stem cell treatments at the hospital. The AIFA report says the Stamina Foundation's treatment did not follow Italy's official path required for clinical approval. So far no scientific publications describing its effectiveness are available. But the halt sparked protests among patients' families who believed the treatment was working. Some appealed to the courts, and as a result a … Continue reading →